SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NeuroSigma, Inc. Release: Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™